Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/17/suppl_7/vii68/347657/mdl955.pdf
Reference33 articles.
1. Biliary tract cancers;De Groen;N Engl J Med,1999
2. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gall-bladder and bile duct cancer;Falkson;Cancer,1984
3. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer;Glimelius;Ann Oncol,1996
4. Combination of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic–biliary carcinomas;Takada;Oncology,1994
5. Epirubicin-sequential methotrexate-5-fluorouracilleucovorin treatment in advanced cancer of the extrahepatic biliary system: A phase II study;Kajanti;Am J Clin Oncol,1994
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing the efficacy and safety of gemcitabine-induced thrombocytopenia/neutropenia and thrombocytopenia interventions in zebrafish;Journal of Genetics and Genomics;2024-09
2. A Transcriptomic Signature for Risk‐Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma;Hepatology;2021-06-15
3. Liver Transplantation for Cholangiocarcinoma;Diagnosis and Management of Cholangiocarcinoma;2021
4. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery;PLOS ONE;2020-09-03
5. Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer;European Journal of Cancer;2020-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3